Consider New Nuplazid for Some Patients With Parkinson's Psychosis

August 2016

The new antipsychotic, Nuplazid (new-PLAH-zid, pimavanserin), will raise questions about treating psychotic symptoms in Parkinson's patients.

Psychosis is common in Parkinson's...partly because the meds used to improve tremors and stiffness may cause hallucinations and delusions.

But antipsychotics block dopamine and can worsen motor function.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote